US European cholesterol guidelines differ in statin use recommendations
The JAMA Network Journals Application of US and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially with one US...
View ArticleValidation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk...
ImportanceThe American College of CardiologyAmerican Heart Association ACCAHA Pooled Cohort risk equations were developed to estimate atherosclerotic cardiovascular disease CVD risk and guide statin...
View ArticleREGARDS Analysis Answers Critics of New CVRisk Equations
They can indeed inform clinical decisions for people considered for statin therapy claims a new analysis of a cohort in which the new risk prediction tool had seemed to overestimate risk. Heartwire
View ArticleAnalysis supports use of risk equations to guide statin therapy
In an analysis of almost 11000 patients an assessment of equations that help guide whether a patient should begin taking a statin cholesterol lowering medication found that observed and predicted 5year...
View ArticleData From Phase 3 Pivotal Studies Show Amgen's Novel Investigational...
THOUSAND OAKS Calif. March 30 2014 PRNewswire ĆAmgen NASDAQ AMGN today announced new detailed data from two Phase 3 pivotal studies that showed treatment with its novel investigational...
View ArticleLowering your cholesterol may improve your sex life
Rutgers University The research conducted at Rutgers Robert Wood Johnson Medical School found that statin medication prescribed to lower cholesterol and decrease the chance of heart attack and stroke...
View ArticleStatin use guidelines for cholesterol vary in US and Europe
Statins are commonly used to lower cholesterol therefore helping to reduce the risk of cardiovascular disease. But new research finds that US and European cholesterol guidelines differ significantly...
View ArticleEvolocumab safely drops LDL cholesterol well below statinonly baseline
The monoclonal antibody evolocumab produced highly significant reductions in lowdensity lipoprotein LDL cholesterol the "bad cholesterol" as an addon to statins in all treatment groups according to...
View ArticleU.S. European cholesterol guidelines differ in statin use recommendations
Application of US and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially with one US guideline recommending...
View ArticleMedical News Today Statin use guidelines for cholesterol vary in US and Europe
Statins are commonly used to lower cholesterol therefore helping to reduce the risk of cardiovascular disease. But new research finds that US and European cholesterol guidelines differ significantly...
View ArticleEvolocumab safely drops LDL cholesterol well below statinonly baseline study...
The monoclonal antibody evolocumab produced highly significant reductions in lowdensity lipoprotein cholesterol the "bad cholesterol" as an addon to statins in all treatment groups according to new data.
View ArticleACC Evolocumab Consistently Cuts Cholesterol CMECE
WASHINGTON MedPage Today The investigational PCSK9 inhibitor evolocumab dramatically lowered LDL cholesterol whether given once or twice a month and across statin insufficient and statin intolerant...
View ArticleAmgen gains on evolocumab update
Amgen Inc. NASDAQAMGN gained $2.79 to $123.34 on Monday after the company for the first time provided detailed data from five Phase III trials of subcutaneous evolocumab AMG 145. The company previously...
View ArticleStatins 'improve erectile dysfunction symptoms'
How statins could boost your love life Cholesterol lowering drugs reduce erectile dysfunction reports the Daily Mail.TheĆpaper reports on a small but wellconducted analysis of existing data into statin...
View ArticleSanofi and Regeneron Report Positive Results With Alirocumab From Phase 2...
BRIDGEWATER N.J. and TARRYTOWN&160;N.Y. April 1 2014 PRNewswire Sanofi EURONEXT SAN and NYSE SNY and Regeneron Pharmaceuticals Inc. NASDAQ REGN today announced that the first Phase 2 study with...
View ArticleNo proof Earl Grey can fight heart disease
A cup of Earl Grey 'as good as statins' at fighting heart disease reports The Daily Telegraph entirely without proof. The science behind this headline did not show Earl Grey was as good as statins a...
View ArticleEarl Grey unproven as replacement for statins
A cup of Earl Grey 'as good as statins' at fighting heart disease reports The Daily Telegraph entirely without proof. The science behind this headline did not show Earl Grey was as good as statins a...
View ArticleRegeneron Sanofi report Japanese alirocumab data
Regeneron Pharmaceuticals Inc. NASDAQREGN and partner Sanofi EuronextSAN; NYSESNY said subcutaneous alirocumab REGN727 given every other week in combination with statin therapy met the primary endpoint...
View ArticleSusquehanna Health Cardiologist Deems New Statin Therapy Guidelines Appropriate
Susquehanna Health SH Cardiologist Dr. Liran Blum said new guidelines established by the American College of Cardiology ACC and American Heart Association AHA regarding the recommended use of...
View Article